SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+29.99%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$618M
AUM Growth
+$618M
(+15%)
Cap. Flow
-$43.5M
Cap. Flow
% of AUM
-7.05%
Top 10 Holdings %
Top 10 Hldgs %
30.62%
Holding
114
New
21
Increased
23
Reduced
33
Closed
17
Top Buys
| 1 |
Perspective Therapeutics
CATX
|
$14.8M |
| 2 |
CYBN
Cybin
CYBN
|
$10.6M |
| 3 |
BridgeBio Pharma
BBIO
|
$9.39M |
| 4 |
SentinelOne
S
|
$7.86M |
| 5 |
Outlook Therapeutics
OTLK
|
$6.82M |
Top Sells
| 1 |
Nova
NVMI
|
$17.2M |
| 2 |
Astria Therapeutics
ATXS
|
$14.6M |
| 3 |
Cartesian Therapeutics
RNAC
|
$14.2M |
| 4 |
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
|
$13.6M |
| 5 |
Tower Semiconductor
TSEM
|
$11.7M |
Sector Composition
| 1 | Healthcare | 75.14% |
| 2 | Technology | 18.02% |
| 3 | Communication Services | 3.09% |
| 4 | Consumer Discretionary | 2.82% |
| 5 | Utilities | 0.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
FUSN
26
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $9.57M | 1.35% | 449,041 -636,598 | -59% | -$13.6M |
|
27
Pharvaris
PHVS
$1.39B
| $9.08M | 1.28% | 392,877 +147,877 | +60% | +$3.42M |
|
28
Mineralys Therapeutics
MLYS
$1.03B
| $8.51M | 1.2% | 658,803 -84,788 | -11% | -$1.09M |
|
29
Day One Biopharmaceuticals
DAWN
$769M
| $8.14M | 1.14% | 492,627 -20,373 | -4% | -$337K |
|
30
Global E Online
GLBE
$5.68B
| $7.59M | 1.07% | 208,784 -61,010 | -23% | -$2.22M |
|
31
WIX.com
WIX
$7.85B
| $7.27M | 1.02% | 52,877 -4,600 | -8% | -$632K |
|
32
Sarepta Therapeutics
SRPT
$1.78B
| $7.2M | 1.01% | 55,614 +43,114 | +345% | +$5.58M |
|
33
Immatics
IMTX
$619M
| $7M | 0.98% | 666,111 +45,000 | +7% | +$473K |
|
34
AbbVie
ABBV
$372B
| $6.92M | 0.97% | 38,000 -8,000 | -17% | -$1.46M |
|
|
35
Outlook Therapeutics
OTLK
$37.8M
| $6.82M | 0.96% | +571,429 | New | +$6.82M |
|
36
Merus
MRUS
$4.98B
| $6.72M | 0.94% | 149,333 -81,000 | -35% | -$3.65M |
|
37
Applied Materials
AMAT
$128B
| $6.6M | 0.93% | +32,000 | New | +$6.6M |
|
38
Camtek
CAMT
$3.78B
| $6.28M | 0.88% | +74,909 | New | +$6.28M |
|
|
39
Nova
NVMI
$7.74B
| $6.23M | 0.87% | 35,106 -96,894 | -73% | -$17.2M |
|
|
40
Tower Semiconductor
TSEM
$6.58B
| $6.01M | 0.84% | 179,600 -348,700 | -66% | -$11.7M |
|
41
89bio
ETNB
$1.34B
| $6M | 0.84% | 515,882 +107,208 | +26% | +$1.25M |
|
|
VIGL
42
DELISTED
Vigil Neuroscience
VIGL
| $5.9M | 0.83% | 1,730,414 +1,195,294 | +223% | +$4.08M |
|
43
Enphase Energy
ENPH
$4.93B
| $5.71M | 0.8% | 47,183 +12,383 | +36% | +$1.5M |
|
44
Ventyx Biosciences
VTYX
$171M
| $5.46M | 0.77% | 992,749 +812,749 | +452% | +$4.47M |
|
45
Taboola.com
TBLA
$991M
| $5.29M | 0.74% | 1,191,070 -533,878 | -31% | -$2.37M |
|
46
4D Molecular Therapeutics
FDMT
$288M
| $5.17M | 0.73% | +162,161 | New | +$5.17M |
|
47
Incyte
INCY
$16.5B
| $5.1M | 0.72% | 89,556 | – | – |
|
48
Rocket Pharmaceuticals
RCKT
$354M
| $4.95M | 0.7% | 183,722 -7,061 | -4% | -$190K |
|
49
Novartis
NVS
$245B
| $4.84M | 0.68% | 50,000 -10,000 | -17% | -$967K |
|
50
Catalyst Pharmaceutical
CPRX
$2.52B
| $4.59M | 0.65% | +288,000 | New | +$4.59M |
|